ARS Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Dorsey Brian | Chief Operating Officer | Sale | 50,000 | $15.00 | $750,000 | 6,024 | Aug 20, 2024 |
| Scott Kathleen D. | Chief Financial Officer | Sale | 12,500 | $16.00 | $200,000 | 13,199 | Aug 20, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 11,756 | $15.61 | $183,511 | 1,499,747 | Aug 20, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 2,300 | $16.26 | $37,398 | 1,497,447 | Aug 20, 2024 |
| Karas Eric | Chief Commercial Officer | Sale | 10,000 | $14.00 | $140,000 | 5,693 | Aug 19, 2024 |
| Dorsey Brian | Chief Operating Officer | Option Exercise | 30,000 | $0.64 | $19,200 | 36,024 | Aug 13, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 35,401 | $12.76 | $451,717 | 1,446,494 | Aug 13, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 14,599 | $11.78 | $171,976 | 1,481,895 | Aug 13, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $11.40 | $570,000 | 1,598,499 | Jul 16, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $11.40 | $570,000 | 1,598,499 | Jul 16, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $9.62 | $481,000 | 1,648,499 | Jul 9, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $9.62 | $481,000 | 1,496,494 | Jul 9, 2024 |
| Shah Pratik | — | Gift | 200,000 | — | — | 1,132,900 | Jun 13, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 2,166 | $9.00 | $19,494 | 1,594,328 | Jun 12, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 2,166 | $9.00 | $19,494 | 1,594,328 | Jun 12, 2024 |
| Shah Pratik | — | Gift | 1,332,950 | — | — | 4,824,554 | Jun 7, 2024 |
| Pratik Shah Living Trust dated June 15, 2011 | — | Other | 2,665,800 | — | — | 7,490,404 | Jun 4, 2024 |
| Shah Pratik | — | Gift | 1,332,900 | — | — | 6,157,504 | Jun 4, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 2,381 | $9.05 | $21,548 | 1,642,193 | May 14, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 44,350 | $9.06 | $401,811 | 1,748,499 | May 14, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $9.34 | $467,000 | 1,798,499 | May 7, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $9.34 | $467,000 | 1,798,499 | May 7, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Option Exercise | 82,733 | $0.84 | $69,496 | 3,359,587 | Apr 23, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Option Exercise | 82,733 | $0.84 | $69,496 | 3,359,587 | Apr 23, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Option Exercise | 119,047 | $0.84 | $99,999 | 4,245,869 | Apr 19, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Option Exercise | 69,444 | $1.44 | $99,999 | 4,315,313 | Apr 19, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $9.28 | $464,000 | 1,647,447 | Apr 16, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $9.28 | $464,000 | 1,647,447 | Apr 16, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $9.28 | $464,000 | 1,898,499 | Apr 9, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $9.28 | $464,000 | 1,898,499 | Apr 9, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | — | Purchase | 437,600 | $9.06 | $3,964,656 | 8,994,374 | Mar 26, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 47,635 | $9.12 | $434,431 | 1,697,447 | Mar 25, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 1,326 | $9.01 | $11,947 | 1,996,131 | Mar 25, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 372 | $9.00 | $3,348 | 1,746,099 | Mar 21, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 100 | $9.00 | $900 | 1,997,457 | Mar 19, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 205 | $9.00 | $1,845 | 1,744,789 | Mar 15, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 48,295 | $9.14 | $441,416 | 1,696,494 | Mar 13, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 1,982 | $9.01 | $17,858 | 2,048,499 | Feb 29, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 1,982 | $9.01 | $17,858 | 2,048,499 | Feb 29, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 24,303 | $9.02 | $219,213 | 1,748,447 | Feb 28, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 100 | $9.01 | $901 | 1,772,750 | Feb 28, 2024 |
| Fitzpatrick Alexander A | Chief Legal Officer | Purchase | 40,000 | $3.62 | $144,800 | 42,969 | Sep 29, 2023 |
| RA Capital Healthcare Fund LP | — | Purchase | 2,508,691 | $2.97 | $7,450,812 | 8,365,465 | Sep 21, 2023 |
| Shawver Laura | — | Option Exercise | 2,997 | $1.27 | $3,806 | 213,343 | Sep 1, 2023 |
| RA CAPITAL MANAGEMENT, L.P. | — | Purchase | 3,750,000 | $6.20 | $23,250,000 | 5,856,774 | Aug 29, 2023 |
| OrbiMed Capital GP VI LLC | — | Purchase | 500,000 | $6.20 | $3,100,000 | 8,019,187 | Aug 29, 2023 |
| Thompson Peter A. | — | Purchase | 500,000 | $6.20 | $3,100,000 | 8,019,187 | Aug 29, 2023 |
| Shawver Laura | — | Sale | 18,897 | $7.06 | $133,413 | 210,346 | Aug 4, 2023 |
| Shawver Laura | — | Sale | 36,281 | $7.09 | $257,232 | 210,346 | Aug 2, 2023 |
| Shawver Laura | — | Option Exercise | 8,858 | $1.27 | $11,250 | 219,204 | Jul 7, 2023 |